ClinicalTrials.Veeva

Menu
C

Centre for Human Drug Research | Leiden, Netherlands

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ACT-541468
DNL151
IW-6463
Clindamycin
DNL343
Erythromycin
POLB 001
Pregabalin
JNJ-42847922
Lu AG06474

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 67 total trials

A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

2-DG-02 is a randomized, placebo-controlled, double-blind Phase 2 study to investigate the efficacy and safety of 2-Deoxy-D-Glucose as a pre-exposure...

Enrolling
Acute Nasopharyngitis
Other: Placebo
Drug: 2-Deoxy-D-glucose

In this study, researchers will learn about a study drug called BIIB115 in healthy male volunteers and in participants with spinal muscular atrophy (...

Enrolling
Muscular Atrophy, Spinal
Healthy Volunteer
Drug: BIIB115-Matching Placebo
Drug: BIIB115

The combined bacteriostatic and immunomodulatory effects of erythromycin and clindamycin will be explored. Treatment effects will be extensively char...

Enrolling
Acne Vulgaris
Drug: 70% topical ethanol solution
Drug: Clindamycin 1% topical lotion formulation

This study will investigate the safety and tolerability of multiple intravenous infusions of NX210c with two ascending doses as well as NX210c pharma...

Enrolling
Healthy Elderly
Drug: Placebo
Drug: NX210c

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Explora...

Enrolling
Muscular Dystrophy, Landouzy Dejerine
Fascioscapulohumeral Muscular Dystrophy
Drug: AOC 1020
Drug: Placebo

This phase 1b trial will evaluate the effects of EP262 in subjects with Chronic Inducible Urticaria (CIndU), including symptomatic dermographism and...

Active, not recruiting
Chronic Inducible Urticaria
Drug: Oral EP262

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urtica...

Enrolling
Chronic Spontaneous Urticaria
Drug: Placebo
Drug: Oral EP262

This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjec...

Active, not recruiting
Stroke
Drug: Placebo
Drug: N,N-Dimethyltryptamine

Trial sponsors

C
Idorsia Pharmaceuticals logo
Denali Therapeutics logo
Pfizer logo
Janssen (J&J Innovative Medicine) logo
Biogen logo
E
Maruho logo
T
Alexza Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems